Showing results (231-240 of 251) with videos related to

Sort By:
Pageof 26
RMD Open|September 2, 2021
Lymphoma complicating rheumatoid arthritis: results from a French case-control studyJoanna Kedra, Raphaele Seror, Philippe Dieudé, et al.
Annals of the Rheumatic Diseases|November 15, 2025
Evaluation of pregnancy outcomes in patients with spondyloarthritis compared to the general population: results from a French national prospective and matched studySabrina Hamroun, Grégoire Martin de Frémont, Nathalie Costedoat-Chalumeau, et al.
Ejhaem|February 2, 2026
Teclistamab in Elderly Patients With Relapsed/Refractory Multiple Myeloma: A Subgroup Analysis of the French RetrosTECtive CohortA Coste, S Godet, S Manier, et al.
Frontiers in Cellular and Infection Microbiology|October 2, 2024
Case report: Personalized triple phage-antibiotic combination therapy to rescue necrotizing fasciitis caused by Panton-Valentine leukocidin-producing MRSA in a 12-year-old boyBrieuc Van Nieuwenhuyse, Mathilde Balcaen, Olga Chatzis, et al.
RMD Open|July 8, 2026
Evaluation of pregnancy outcomes in patients with rheumatoid arthritis compared with the general population: results from a French national prospective and matched studySabrina Hamroun, Grégoire Martin de Frémont, Nathalie Costedoat-Chalumeau, et al.
Journal of Visualized Experiments : Jove|August 27, 2019
Translational Brain Mapping at the University of Rochester Medical Center: Preserving the Mind Through Personalized Brain MappingBradford Z Mahon, Jeffrey A Mead, Benjamin L Chernoff, et al.
Annals of the Rheumatic Diseases|November 20, 2024
Real-life use of the PEXIVAS reduced-dose glucocorticoid regimen in granulomatosis with polyangiitis and microscopic polyangiitisSophie Nagle, Yann Nguyen, Mary-Jane Guerry, et al.
Annals of the Rheumatic Diseases|February 7, 2025
Real-life use of the PEXIVAS reduced-dose glucocorticoid regimen in granulomatosis with polyangiitis and microscopic polyangiitisSophie Nagle, Yann Nguyen, Mary-Jane Guerry, et al.
European Journal of Cancer (Oxford, England : 1990)|March 16, 2020
The 2016-2019 ImmunoTOX assessment board report of collaborative management of immune-related adverse events, an observational clinical studyJean-Marie Michot, Ariane Lappara, Jérôme Le Pavec, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 12, 2014
The clinical spectrum and therapeutic management of hypocomplementemic urticarial vasculitis: data from a French nationwide study of fifty-seven patientsMarie Jachiet, Béatrice Flageul, Alban Deroux, et al.
Pageof 26